Evaluation the Viability of the Saccharomyces Boulardii Bld-3 and its Influence on the Colonic Microbiota Composition by SHIME-Reference-Cited by-同舟云学术

Evaluation the Viability of the Saccharomyces Boulardii Bld-3 and its Influence on the Colonic Microbiota Composition by SHIME

Published:2018-08-20 Issue: Volume: Page:012-017
ISSN:2641-3043
Container-title:Journal of Food Science and Nutrition Therapy
language:
Short-container-title:J Food Sci Nutr The

Author:

Yan Zhang

Publisher

Peertechz Publications Private Limited

Subject

Applied Mathematics,General Mathematics

Link

https://www.peertechzpublications.com/articles/JFSNT-4-115.pdf

Reference25 articles.

1. 1. Adam P (1976) Essais cliniques controlés endouble insu de l'ultra-levure lyophilisée (étude multicentrique par 25 médecinsde 388 cas). Méd Chir Dig 5: 401-406. Link: https://tinyurl.com/yby2ojlt

2. 2. Blehaut H, Massot J, Elmer GW, Levy RM (1989) Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispos 10:353-364. Link: https://tinyurl.com/ya6ppy8x

3. 3. Bleichner G, Blehaut H, Mentec H,Moyse D (1997) Sacchromyces boulardii prevents diarrhoea in critically ill tube-fed patients. A multicenter, randomized, double-blind-placebo-controlled trial. Intensive Care Med 23: 517-523. Link: https://tinyurl.com/y853vs8o

4. 4. Buts JP (1999) Mechanisms of action of biotherapeutic agents. In Elmer GW, McFarland LV, Surawicz CM (eds) Biotherapeutic agents and infectious disease. Humana Pres, Totowa, NJ 27-46. Link: https://tinyurl.com/y98t2a7a

5. 5. Buts JP, Dekeyser N, Stilmant C, Delem E, Smets F, et al. (2006) Saccharomyces boulardii produces in rat small intestine a novel protein phosphatase that inhibits Escherichia coli endotoxin by dephosphorylation. Pediatric Res 60: 24-29. Link: https://tinyurl.com/ycs8dfp6